The following data is part of a premarket notification filed by Carmel Pharma Ab. with the FDA for Phaseal.
Device ID | K023747 |
510k Number | K023747 |
Device Name: | PHASEAL |
Classification | Set, I.v. Fluid Transfer |
Applicant | CARMEL PHARMA AB. BOX 5352 Gothenburg, SE 40228 |
Contact | Kjell Andreasson |
Correspondent | Kjell Andreasson CARMEL PHARMA AB. BOX 5352 Gothenburg, SE 40228 |
Product Code | LHI |
CFR Regulation Number | 880.5440 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Special |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2002-11-08 |
Decision Date | 2002-11-15 |
Summary: | summary |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PHASEAL 75322844 2471820 Live/Registered |
Carmel Pharma AB 1997-07-11 |